ABL:NSD-Abacus Life Inc. (USD)

COMMON STOCK | Insurance - Life |

Last Closing

USD 10.3

Change

-0.46 (-4.23)%

Market Cap

USD 0.66B

Volume

5.26K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-14 )

ETFs Containing ABL

BNKD MicroSectors US Big Banks.. 10.00 % 0.00 %

N/A

USD 0.01B
BNKO 10.00 % 0.00 %

N/A

N/A
BNKU MicroSectors US Big Banks.. 10.00 % 0.00 %

N/A

USD 0.30B
BNKZ 10.00 % 0.00 %

N/A

N/A
KNAB 10.00 % 0.00 %

N/A

N/A
BNKS:LSE iShares S&P U.S. Banks 7.87 % 0.00 %

-0.02 (0.02%)

USD 0.28B
FAZZ 7.84 % 0.45 %

N/A

N/A
BFIN-U:CA 7.74 % 0.00 %

N/A

N/A
RWW 6.55 % 0.46 %

N/A

N/A
RWW 6.55 % 0.00 %

N/A

N/A
RWW 6.55 % 0.69 %

N/A

N/A
RWW 6.55 % 0.00 %

N/A

N/A
RWW 6.55 % 0.46 %

N/A

N/A
RUBY-U:CA RBC U.S. Banks Yield Inde.. 4.87 % 0.00 %

N/A

N/A
SXLF:LSE SPDR S&P U.S. Financials .. 4.82 % 0.00 %

+0.06 (+0.02%)

USD 0.37B
SYV 4.49 % 0.60 %

N/A

N/A
FINZ 4.46 % 0.95 %

N/A

N/A
JHMF 3.74 % 0.47 %

N/A

N/A
QMJ 3.71 % 0.00 %

N/A

N/A
SDGA 3.43 % 0.00 %

N/A

N/A
AMCA 3.16 % 0.15 %

N/A

N/A
BVNSC 3.09 % 0.00 %

N/A

N/A
UYG ProShares Ultra Financial.. 2.96 % 0.95 %

N/A

USD 0.65B
WFIN:LSE SPDR® MSCI World Financi.. 2.85 % 0.00 %

+0.11 (+0.02%)

USD 0.33B
XDWF:LSE db x-trackers MSCI World .. 2.85 % 0.00 %

+0.06 (+0.02%)

USD 0.62B
FBU:CA 2.80 % 0.84 %

N/A

N/A
XMUD:LSE Xtrackers - MSCI USA Swap.. 2.75 % 0.00 %

+0.44 (+0.02%)

USD 4.45B
XMUS:LSE Xtrackers MSCI USA Swap U.. 2.75 % 0.00 %

+5.00 (+0.02%)

USD 4.45B
ZACE:CA BMO U.S. All Cap Equity F.. 2.59 % 0.00 %

+0.01 (+0.02%)

CAD 0.03B
DEW WisdomTree Global High Di.. 2.04 % 0.58 %

N/A

USD 0.10B
VTRN 1.97 % 0.00 %

N/A

N/A
EXT 1.75 % 0.28 %

N/A

N/A
WKLY 1.71 % 0.00 %

N/A

N/A
CLU:CA 1.50 % 0.72 %

N/A

N/A
DHVW 1.43 % 0.10 %

N/A

N/A
SFLA 1.29 % 0.00 %

N/A

N/A
FNDB Schwab Fundamental U.S. B.. 1.27 % 0.25 %

N/A

USD 0.75B
UC07:LSE UBS (Irl) plc - MSCI USA .. 1.26 % 0.00 %

-34.00 (0.02%)

USD 0.62B
GHS 1.19 % 0.48 %

N/A

N/A
SPLX 1.17 % 0.00 %

N/A

N/A
ROLA 1.16 % 0.00 %

N/A

N/A
VIXH 1.13 % 0.60 %

N/A

N/A
OEW 1.11 % 0.40 %

N/A

N/A
ONEK 1.05 % 0.10 %

N/A

N/A
THRK 0.98 % 0.10 %

N/A

N/A
GEND:LSE Amundi Global Gender Equa.. 0.86 % 0.00 %

-0.04 (0.02%)

USD 0.05B
ELLE:LSE Amundi Global Gender Equa.. 0.86 % 0.00 %

-0.02 (0.02%)

USD 0.05B
TERM 0.79 % 0.64 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Insurance - Life) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.63% 100% F 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.63% 80% B- 70% C-
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.66B 50% F 68% D+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.